D Noel
Overview
Explore the profile of D Noel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
979
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dilly B, Gremain V, Masmoudi W, Noel D
Rev Med Interne
. 2022 May;
43(9):570-571.
PMID: 35623926
No abstract available.
2.
Petitjean N, Dusfour G, Canadas P, Maumus M, Valorge P, Devic S, et al.
Mater Sci Eng C Mater Biol Appl
. 2021 Feb;
121:111800.
PMID: 33579447
Articular cartilage is made of chondrocytes surrounded by their extracellular matrix that can both sense and respond to various mechanical stimuli. One of the most widely used in vitro model...
3.
Maumus M, Noel D, Ea H, Moulin D, Ruiz M, Hay E, et al.
Osteoarthritis Cartilage
. 2020 Jul;
28(10):1373-1384.
PMID: 32659345
Objective: TGFβ is a key player in cartilage homeostasis and OA pathology. However, few data are available on the role of TGFβ signalling in the different OA phenotypes. Here, we...
4.
Dusfour G, Maumus M, Canadas P, Ambard D, Jorgensen C, Noel D, et al.
Mater Sci Eng C Mater Biol Appl
. 2020 May;
112:110808.
PMID: 32409025
The prevalence of diseases that affect the articular cartilage is increasing due to population ageing, but the current treatments are only palliative. One innovative approach to repair cartilage defects is...
5.
Ruiz M, Maumus M, Fonteneau G, Pers Y, Ferreira R, Dagneaux L, et al.
Osteoarthritis Cartilage
. 2018 Dec;
27(3):493-503.
PMID: 30502449
Objective: Transforming growth factor-β (TGFβ) is a major regulator of cartilage homeostasis and its deregulation has been associated with osteoarthritis (OA). Deregulation of the TGFβ pathway in mesenchymal stem cells...
6.
Marie I, Gehanno J, Bubenheim M, Duval-Modeste A, Joly P, Dominique S, et al.
Autoimmun Rev
. 2017 Feb;
16(3):223-230.
PMID: 28137480
Objective: This case control study assessed: 1) the relationship of systemic sclerosis (SSc) related to exposure to heavy metals; and 2) the risk of SSc related to occupational exposure in...
7.
Luz-Crawford P, Ipseiz N, Espinosa-Carrasco G, Caicedo A, Tejedor G, Toupet K, et al.
Ann Rheum Dis
. 2016 Mar;
75(12):2166-2174.
PMID: 26964143
Objectives: To define how peroxisome proliferator-activated receptor (PPAR) β/δ expression level in mesenchymal stem cells (MSCs) could predict and direct both their immunosuppressive and therapeutic properties. PPARβ/δ interacts with factors...
8.
Manferdini C, Maumus M, Gabusi E, Paolella F, Grassi F, Jorgensen C, et al.
Osteoarthritis Cartilage
. 2015 Nov;
23(11):2045-57.
PMID: 26521751
Objective: To define whether good manufacturing practice (GMP)-clinical grade adipose stem cell (ASC)-derived conditioned medium (CM) is as effective as GMP-ASC in modulating inflammatory and catabolic factors released by both...
9.
Pers Y, Ruiz M, Noel D, Jorgensen C
Osteoarthritis Cartilage
. 2015 Nov;
23(11):2027-35.
PMID: 26521749
Osteoarthritis (OA) is the most common form of degenerative arthritis, mainly characterized by the degradation of articular cartilage and associated with subchondral bone lesions. Novel therapeutic approaches for OA include...
10.
Luz-Crawford P, Tejedor G, Mausset-Bonnefont A, Beaulieu E, Morand E, Jorgensen C, et al.
Arthritis Rheumatol
. 2015 Feb;
67(6):1514-24.
PMID: 25708718
Objective: Mesenchymal stem cells (MSCs) are potent immunosuppressive cells that have shown promise in the treatment of rheumatoid arthritis (RA). Deciphering the intrinsic characteristics of MSCs that correlate with their...